Considering the ongoing demand, the market players are undertaking initiatives to develop advanced assisted living technologies, specifically assistive robots. For instance, in July 2025, MIT engineers team have successfully built and tested an Elderly Bodily Assistance Robot (E-BAR), a form of mobile robot to physically support the elderly people and prevent them from falling. As market players continue to innovate advanced assistive robots, it is expected that eldercare assistive robots market...

The global PFAS testing market is estimated to grow from USD 249.1 million in 2025 to reach USD 279.1 million in 2026 and USD 1,209.5 million by 2040, representing a CAGR of 11% during the forecast period 2026 to 2040. In January 2025, SGS acquired RTI Laboratories with the aim to expand their PFAS lab testing capabilities in North American region. In February 2025, TUV Rheinland announced the expansion of its PFAS testing capabilities by upgrading the testing services for PFAS analytes in plast...

The Alzheimer’s disease market is estimated to grow from USD 11.3 billion in 2024 to reach USD 12.4 billion in 2025 and USD 29.4 billion by 2035, representing a higher CAGR of 9% during the forecast period. As per the data provided by the Alzheimer's Association, over 7 million Americans are currently suffering from Alzheimer's disease. Further, the cases are likely to reach nearly 13 million by 2050. In June 2025, Cure Parkinson and Alzheimer’s Research UK entered into a strategic partnersh...

The global pain management devices market, valued at USD 8.39 billion in 2025, is projected to reach USD 8.84 billion in 2026 and USD 13.32 billion by 2035, with a 9.6% CAGR during the forecast period 2026 to 2035. Pain management typically involves the deployment of devices that can alleviate the suffering of individuals with musculoskeletal, spinal and neuropathic pain. In May 2025, Matri launched Matri Pro, India’s slimmest and most advanced device for assisting in relief from menstrual...

The global sustainable packaging market, valued at USD 10.29 billion in 2025, is projected to reach USD 10.95 billion in 2026 and USD 19.19 billion by 2035, with a 6.4% CAGR during the forecast period 2026 to 2035. In June 2025, Mondi has entered into a collaboration with Saga Nutrition in order to create a recyclable packaging solution for the latter company’s dry pet food range. Further, it is worth highlighting that the sustainable packaging market in Latin America is expected to grow a...

The global biotherapeutics market, valued at USD 481 billion in 2025, is projected to reach USD 528 billion in 2026 and USD 1,048 billion by 2035, with a 7.9% CAGR during the forecast period 2026 to 2035. Biotherapeutics industry is anticipated to witness upward trajectory owing to the growing shift towards biologics for treating wide range of diseases, including cancer, infectious diseases, and autoimmune disorders. The recent USFDA accelerated approval of AbbVie's Emrelis™ (telisotuzumab ved...

The breast implants market valued at USD 20.9 billion in 2024, is project to reach USD 22.9 billion in 2025 and USD 58.2 billion by 2035, representing a higher CAGR of 9.8% during the forecast period 2025 to 2035. In terms of gender, the females segment holds the highest share (nearly 90%) of the market.  Based on the distribution channel, indirect distribution channel segment holds the largest market share. North America captures the majority of the market share.

The click chemistry and bioorthogonal chemistry market, valued at USD 1.04 billion in 2025, is projected to reach USD 1.14 billion in 2026 and USD 3.65 billion by 2040, with a 8.7% CAGR during the forecast period 2026 to 2040. In December 2024, Veraxa Biotech signed a research and development agreement with Navigo Proteins for the development of radiopharmaceuticals intended for the treatment of oncological disorders. In January 2025, Synaffix out-licensed their GlycoConnect technology (utilizin...

The remote patient monitoring market is estimated to grow from USD 7.2 billion in 2024 to reach USD 9.4 billion in 2025 and USD 88.0 billion by 2035, representing a higher CAGR of 25% during the forecast period. Notably, as per a report published by the Centers for Disease Control and Prevention in 2024, nearly 129 million people in the United States are suffering from at least one chronic disease. As the global demand of user-friendly, cost-effective and efficient data tracking devices increase...

The precision farming market is estimated to grow from USD 10.4 billion in 2024 to reach USD 11.2 billion in 2025 and USD 27.3 billion by 2035, representing a higher CAGR of 9.3% during the forecast period.In May 2025, HyFarm announced a partnership with Fyllo for incorporating precision farming in the cultivation of Potato, using the latter’s precision technology. In April 2025, Topcon Agriculture launched a solution named Value Line Steering to revolutionize agriculture and make precision fa...

The global veterinary regenerative medicine market size, valued at USD 388 Million in 2025, is projected to reach USD 437 Million in 2026 and USD 1,189 Million by 2035, representing a CAGR of 11.8% during the forecast period. In terms of product, stem cell therapies is securing 53% of the market share driven by the widespread adoption of these therapies to treat wounds, damages tissues and chronic conditions. With regards to end user, the veterinary hospitals / clinics segment holds the highest...

The global regenerative medicine for spinal cord market size, valued at USD 16 million in 2025, is projected to reach USD 54 million in 2026 and USD 655 million by 2035, representing a CAGR of 32% during the forecast period, 2026 to 2035. The growth in the market is driven by strong scientific progress, expanding clinical trial activity, and increasing investment in advanced therapies such as stem cells and gene-based approaches. The global market for regenerative medicine for spinal cord injuri...

The electronic batch records market is estimated to grow from USD 1.28 billion in 2025 to reach USD 1.43 billion in 2026 and USD 9.62 billion by 2040, representing a higher CAGR of 14.6% during the forecast period 2026 to 2040. In January 2025, InstantGMP entered into a strategic partnership with Corsair Pharma in order to enhance the later company’s quality of production and streamline documentation by providing InstantGMP’s Quality Management System (QMS) and Document Management System (DM...

The global nasal drug delivery market, valued at USD 6.1 billion in 2025, is projected to reach USD 8.1 billion in 2026 and USD 26.8 billion by 2035, with a 14.2% CAGR during the forecast period 2026 to 2035. The global market highlights the market segmentation of nasal drug delivery, based upon their target indication into acute repetitive clusters, anaphylaxis, COVID-19, dry eye disease, hypoglycemia, influenza, major depressive disorder, migraine, nasal polyps, and prader-willi syndrome.

The global AI in rare disease diagnostics market, valued at USD 1.36 billion in 2024, is projected to reach USD 1.90 billion in 2025 and USD 22.12 billion by 2035, with a CAGR of 27.8% during the forecast period 2025 to 2035. For instance, in May 2025, SeqOne (US) has secured €20 million funds to expand its AI-based software for next-generation sequencing data analysis in rare disease and oncology. Given the increasing prevalence and increasing shift towards AI technology for disease diagnosi...

The global breast cancer diagnostics market size, valued at USD 5.05 billion in 2024, is projected to reach USD 5.47 billion in 2025 and USD 10.51 billion by 2035, representing a CAGR of 6.8% during the forecast period. Based on the product type, the instrument-based products (imaging and biopsy) segment dominates the market by holding 72% share. On the basis of regional analysis, North America accounts for 46% of the overall market share due to high prevalence, technological advancements, and g...

The global AI in skincare market, valued at USD 1.19 billion in 2024, is projected to reach USD 1.37 billion in 2025 and USD 4.28 billion by 2035, with a CAGR of 12.1% during the forecast period. This market is growing due to the growing adoption of AI algorithm for skin analysis to prepare personalized skincare solutions. In August 2025, Debut (US) raised USD 20 million to accelerate the expansion of its AI-based ingredient discovery platform to enhance innovation in skin longevity. Kult (India...

Market players, such as Medtronic (Ireland), Abbott (US), and Roche (Switzerland) are increasingly focused on the development of smart medical devices, including hearing aid solutions, smart drug delivery, neurostimulation devices and smart inhalers for managing chronic conditions. This consistent revolution, heightened acceptance and proliferation of market players has made smart medical devices market highly competitive.

The global needles market size is projected to grow from $8.1 billion in 2025 to $14.7 billion by 2035, representing a CAGR of 6.1% during the forecast period. Over the years, the incidence of chronic conditions, such as diabetes, autoimmune diseases, heart diseases, and cancer has risen significantly. The conventional needle segment holds majority of the shares (69%) in the current market. However, this percentage distribution is likely to change during the forecast period, till 2035. Over 475...

The flow cytometry services market, valued at USD 3.74 billion in 2025, is projected to reach USD 4.10 billion in 2026 and USD 9.23 billion by 2035, with a 9.44% CAGR during the forecast period 2026 to 2035. High demand of flow cytometry analysis for various applications in the medical industry, coupled with stringent regulatory guidelines, has driven the need for advanced flow cytometry services that enable rapid, accurate, and high-throughput analysis of cell populations.